Abercrombie & Fitch Company
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +37.5% | -29.7% | +11.1% | +6.6% | +31.1% | -30.8% | +10.1% | +6.8% | +29.4% | -33.3% | +13.7% | – | |
| – | +45.5% | -36.4% | +15.9% | +6.1% | +44.8% | -31.7% | +8.3% | +7.1% | +39.9% | -32.6% | -19.7% | – | |
| – | +33.2% | -25.8% | +8.7% | +6.9% | +23.8% | -30.2% | +11.3% | +6.6% | +23.1% | -33.8% | +36.9% | – | |
| – | +18.9% | -1.9% | -6.0% | +5.7% | +12.7% | -17.5% | +0.2% | +10.3% | -6.0% | +0.5% | +12.1% | – | |
| – | +26.1% | -20.7% | +2.4% | +8.4% | +18.2% | -19.4% | -4.9% | +18.5% | +16.2% | -24.5% | +13.3% | – | |
| – | +61.4% | -41.7% | +35.3% | +2.1% | +42.8% | -60.3% | +103.5% | -25.0% | +52.2% | -63.5% | +193.7% | – | |
| – | -21.9% | -13.6% | -10.2% | -89.0% | -5.3% | +22.6% | -6.2% | -11.3% | -1.1% | -17.3% | +24.7% | – | |
| – | +65.7% | -40.8% | +34.1% | +4.0% | +40.9% | -59.1% | +93.1% | -23.0% | +50.6% | -61.2% | +176.7% | – | |
| – | +68.0% | -70.3% | +129.6% | +19.1% | +39.0% | -64.7% | +147.4% | -30.2% | +47.4% | -61.6% | +187.9% | – | |
| – | +64.7% | -28.1% | +17.0% | -0.9% | +41.9% | -57.1% | +75.8% | -20.1% | +52.3% | -61.0% | +173.7% | – | |
| – | +50.7% | -33.9% | +26.4% | +1.2% | +32.7% | -51.2% | +67.5% | -19.1% | +41.6% | -51.7% | +90.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.